R.PR
REGISTERED-PRINCIPAL REGISTER
01/04/2022
Back to search
Official data from USPTO
AUDUBON
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
04/21/2023
Trademark type
Combined
Nice classes
42, 44
Filing date
10/06/2020
Registration date
01/04/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/04/2022
Last transaction
04/21/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
05/25/2017
First use in commerce
05/25/2017
Drawing code
3
Owner type
16
Owner location
Houston, TX, US
Examiner
CHADAB, SETH WILLIG
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "AUDUBON" in black with an image of a cell to the left stylized so that the varying cell structures are shaded differently and the membranes between the structures are frayed to look like a pompom. The cell having a yellow center, followed by a pink layered border and a purple border on the outside.
Holders and representatives
Holders
Audubon Health Group, LLC
Representatives
Robert Devin Ricci KEAN MILLER LLP
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Providing medical and scientific research information in the field of human pharmaceuticals and human clinical trials; conducting research and clinical trials in the field of human oncology and cancer research; Providing a website featuring educational information in the field of human clinical research; Medical and scientific researchconducting human clinical trials for others; Providing human medical testing services and information in the field of human cancer research and disease classification; technical research and consulting in the field of human pharmaceutical studies; Human pharmaceutical research services; human Pharmaceutical research and development; testing of human pharmaceuticals; Biotechnology research related to humans; Medical research related to humans; Human DNA analysis services for scientific research purposes; Human medical and scientific research in the field of molecular profiling and biomarker discovery in cancer patients; human medical and scientific research in the field of cancer treatment; Providing research information in the nature of human medical research data pertaining to cancer and its treatment; Management of clinical and translational trials in the field of human cancer treatment for others in the nature of conducting clinical trials for others; Providing clinical trial information in the nature of research data pertaining to cancer; developmentvalidationcertification of human clinical trials and tests; Designresearchdevelopment and testing services in the field of human pharmaceuticalsbiobankingcancer research; Preclinical research services in the field of human biospecimens collections
Class 44
collection and preservation of human biologicalshuman tissueblood and bodily fluids; Biobank servicesproviding access to a collection of human biologicalshuman tissueblood and bodily fluids; Providing human medical information in the nature of medical data pertaining to cancer and its treatment; providing tissue biobank servicesaccess to a biobank of human biological and tissue samples; Human medical testing for diagnostic or treatment purposes; Dispensing of pharmaceuticals to humans
Publications
History of USPTO decisions and trademark events.
21 publications found
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
11/25/2021
CHPB
POST PUBLICATION AMENDMENT - ENTERED
11/24/2021
APET
ASSIGNED TO PETITION STAFF
11/24/2021
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
11/12/2021
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
06/16/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/18/2021
PUBO
PUBLISHED FOR OPPOSITION
05/18/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/28/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/13/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
04/13/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/13/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
04/13/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/13/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/09/2021
GNRT
NON-FINAL ACTION E-MAILED
03/09/2021
CNRT
NON-FINAL ACTION WRITTEN
03/09/2021
DOCK
ASSIGNED TO EXAMINER
03/04/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/21/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/20/2020
NWAP
NEW APPLICATION ENTERED
10/09/2020
Continuous trademark protection
Get notified about every new filing that threatens AUDUBON or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.